AGY

Allergy therapeutics plc

How common is peanut allergy?

Peanuts are a common cause of food allergy, caused when the immune system reacts to the protein found in peanuts. Peanut allergy affects around 2% (1 in 50) of children

Allergy therapeutics plc

Allergy Therapeutics record level of pre R&D operating profit

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapy, today announces its preliminary results for the year ended 30 June 2020. Financial Highlights ·      7% revenue

Allergy therapeutics plc

Can you get autumn hay fever?

The arrival of autumn is commonly welcomed with a sigh of relief for those with hay fever symptoms who have suffered throughout spring and summer. The most common groups of

Allergy therapeutics plc

Have you got COVID-19 or hay fever?

Spring has sprung and in some parts of the country that means those of us who get hay fever are eyeing pollen-laden plants and windy weather forecasts with suspicion. But

Allergy therapeutics plc

Allergy Therapeutics secures VLP technology platform

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced further investment in virus-like particle (VLP) technology for applications beyond the allergy immunotherapy field. Allergy

Diversified Energy Company plc
Diversified Energy CEO Rusty Hutson discusses the Maverick Natural Resources acquisition and its impact on growth, margins, and sustainability goals.
Cerillion
In an exclusive interview with DirectorsTalk, Cerillion plc CEO Louis Hall discusses the $11.4 million telecom contract and its impact on the company's growth strategy.
Pan African Resources
Discover the success behind Pan African Resources plc and its outperformance as discussed by Gervais Williams, Co-Fund Manager of Diverse Income Trust plc.
One Health Group plc
In an exclusive interview, One Health Group plc CEO Adam Binns discusses the company's partnership with the NHS, operational growth, and future plans.
Ilika plc
In an exclusive interview, Ilika plc CEO Graeme Purdy discusses progress with Stereax & Goliath, exciting technical milestones, and competition with peers.
Arbuthnot Banking Group plc
Gervais Williams discusses Arbuthnot Banking Group plc's success and potential growth in an exclusive interview with DirectorsTalk.
Fidelity Emerging Markets
Explore the potential of emerging markets equities for growth and diversification. Learn how active management strategies can maximize returns and navigate market dynamics.
Team plc
Last week’s Wall Street volatility, fueled by tariff threats and tech struggles, raised investor concerns. Economic uncertainty looms with conflicting data.
Fidelity China Special Situations
Chinese and Hong Kong tech stocks surge as AI startup DeepSeek's breakthrough model ignites investor confidence in China's AI prowess.
Fidelity European Trust
European stock markets soar as BP shines amid fresh US tariff threats. Investors navigate opportunity and risk amid trade policy shifts and corporate shakeups.
Fidelity Special Values
Global markets steady despite Trump tariff threats. FTSE 100 up as investors weigh impact of import tax. BP surges after activist stake.
Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.
Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.
SAE Renewables (LON:SAE) advances energy ambitions with £1.3M payment for Uskmouth BESS project. Analyst sees positive impact on future projects.
hVIVO plc
hVIVO plc achieves milestone with £3.2 million hLAB contract, showcasing growth in laboratory services. Read about the company's latest achievement here.
Greggs
Greggs plc (LON:GRG) shines in tough market conditions, delivering solid FY24 results with revenue of £2,014 million and strong growth.